Your browser doesn't support javascript.
loading
Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
Wang, Xiaoxun; Che, Xiaofang; Yu, Yang; Cheng, Yu; Bai, Ming; Yang, Zichang; Guo, Qiqiang; Xie, Xiaochen; Li, Danni; Guo, Min; Hou, Kezuo; Guo, Wendong; Qu, Xiujuan; Cao, Liu.
Afiliação
  • Wang X; Institute of Translational Medicine, Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical Universi
  • Che X; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Yu Y; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Cheng Y; Institute of Translational Medicine, Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical Universi
  • Bai M; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Yang Z; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Guo Q; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Xie X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Li D; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Guo M; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Hou K; Institute of Translational Medicine, Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical Universi
  • Guo W; Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, China Medical University, Shenyang, 110001, China.
  • Qu X; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Cao L; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
J Exp Clin Cancer Res ; 39(1): 221, 2020 Oct 20.
Article em En | MEDLINE | ID: mdl-33081836
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Autofagia / Neoplasias Gástricas / Fibronectinas / Integrina alfa5 / Fator A de Crescimento do Endotélio Vascular / Hipóxia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Autofagia / Neoplasias Gástricas / Fibronectinas / Integrina alfa5 / Fator A de Crescimento do Endotélio Vascular / Hipóxia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido